Back to Search
Start Over
Cash Injection for Biologic Drugs.
- Source :
-
Chemical Week . 2/8/2010, Vol. 172 Issue 4, p21-23. 3p. - Publication Year :
- 2010
-
Abstract
- The article discusses the growth in opportunities for contract manufacturing of biologics. According to HighTech business Decisions president William Downey, the biologics contract manufacturing market is set to grow at an average compounded annual growth rate of 16 percent over the next five years and reach 5.4 billion U.S. dollars. As an example, Reliance Industries is growing its activities in biologics manufacture, in part through Reliance Genemedix. In addition, Wacker Chemie says its biologics business is expanding capacity to meet higher demand.
- Subjects :
- *PHARMACEUTICAL industry
*BIOLOGICALS
*PRODUCTION increases
*INDUSTRIAL capacity
Subjects
Details
- Language :
- English
- ISSN :
- 0009272X
- Volume :
- 172
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Chemical Week
- Publication Type :
- Periodical
- Accession number :
- 48294741